---
HeadNode:
- name: Program
  count: 4
  Prefix: Program

#Nodes to be included in the data graph.
#Only nodes in the IncludeNodes section will be created.
#Includes nodes in the hierarchy in which they occur in the model.
IncludeNodes:
  - Adverse_Events_Table
  - Biopsy_Surgical_Procedures_Table
  - Cellular_Immunotherapy_Table
  - Concomitant_Medications_Table
  - Course_Timing_Table
  - Cytology_Table
  - Demographics_Table
  - Disease_Characteristics_Table
  - Disease_Phase_Timing_Table
  - Echocardiogram_Table
  - Growing_Teratoma_Syndrome_Table
  - Histology_Table
  - Immunohistochemistry_Table
  - Labs_Table
  - Medical_History_Table
  - Minimal_Residual_Disease_Table
  - Molecular_Analysis_Table
  - Myeloid_Sarcoma_Involvement_Table
  - Non_Protocol_Therapy_Table
  - Non_protocol_Therapy_Table_2
  - Off_Protocol_Therapy_Study_Table
  - Patient_Reported_Outcomes_Metadata_Table
  - Program
  - Radiation_Therapy_Table
  - Secondary_Malignant_Neoplasm_Table
  - Staging_Table
  - Stem_Cell_Transplant_Table
  - Study
  - Subject_Characteristics_Table
  - Subject_Response_Table
  - Survival_Characteristics_Table
  - Total_Dose_Table
  - Transfusion_Medicine_Procedures_Table
  - Tumor_Assessment_Table
  - Vitals_Table

#Properties for which synthetic values need to be created.
#Assumption: property names are duplicated among node types, ie, a property never belongs
#to more than one node type.

IncludeProperties:
  Adverse_Events_Table:
    - AGE_AT_AE
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - ADVERSE_EVENT
    - AE_CODE
    - AE_SYSTEM
    - AE_SYSTEM_VERSION
    - AE_GRADE
    - AE_ATTRIBUTION
    - AE_OUTCOME
    - AE_ICU
    - AE_MEDICATION
    - AE_INTERVENTION
    - AE_MED_INTERVENTION_DETAIL
    - AE_PATHOGEN
    - AE_PATHOGEN_CONFIRMATION
    - GVHD_ACUITY
    - GVHD_ORGAN
    - AGE_AT_AE_RESOLVED
    - AVN_JOINT
    - AVN_JOINT_LATERALITY
    - AVN_METHOD
    - ORTHOPEDIC_PROCEDURE
    - INFECTION_CLASSIFICATIO
  Biopsy_Surgical_Procedures_Table:
    - AGE_AT_PROCEDURE
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - TUMOR_CLASSIFICATION
    - TUMOR_TISSUE_TYPE
    - PROCEDURE_SITE
    - PROCEDURE_LATERALITY
    - PROCEDURE_TYPE
    - SURGERY_TYPE_LIMB
    - AMPUTATION_TYPE
    - SURGERY_TYPE_LIMB_SALVAGE
    - RECONSTRUCTION_TYPE
    - PROCEDURE_EXTENT
    - MARGINS
    - BIOPSY_TYPE
    - MET_NON_LUNG_MGMT
    - MET_LUNG_MGMT
    - LOCALIZATION_TECHNIQUE
    - Biopsy
  Cellular_Immunotherapy_Table:
    - AGE_AT_IMT_START
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - IMT_TYPE
  Concomitant_Medications_Table:
    - AGE_AT_MEDICATION_START
    - AGE_AT_MEDICATION_END
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - MEDICATION
    - MEDICATION_ADMN_STATUS
  Course_Timing_Table:
    - COURSE
    - COURSE_NUMBER
    - AGE_AT_COURSE_START
    - AGE_AT_COURSE_END
    - AGE_AT_COURSE_ANC_500
    - AGE_AT_TXASSIGN
  Cytology_Table:
    - AGE_AT_CYTOLOGY
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - MALIGNANT_CELLS
    - CYTOLOGY_SPEC_TYPE
  Demographics_Table:
    - SEX
    - RACE
    - ETHNICITY
  Disease_Characteristics_Table:
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - FAB_TYPE
    - WHO_AML
    - DETECTION_METHOD
    - DISEASE_SITE
    - CNS_DISEASE_STATUS
    - MPAL
    - MLDS
    - TAMDS
    - SECONDARY_AML
    - LANSKY
    - KARNOFSKY
    - GPOH_SCORE
    - IGCCC_RISK_GROUP
    - MAGIC_RISK_GROUP
    - ALL_TYPE
    - HIST_ICD_O_MORPH
    - BULK_MED_MASS
    - PRIOR_STEROIDS_WEEK
    - PRIOR_STEROIDS_MONTH
  Disease_Phase_Timing_Table:
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - AGE_AT_DISEASE_PHASE
    - YEAR_AT_DISEASE_PHASE
  Echocardiogram_Table:
    - AGE_AT_ECHO
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - ECHO_TEST
    - ECHO_RESULT
    - ECHO_RESULT_NUMERIC
    - ECHO_RESULT_UNIT
  Growing_Teratoma_Syndrome_Table:
    - AGE_AT_GTS
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - GTS_TREATMENT
  Histology_Table:
    - AGE_AT_HIST_ASSESSMENT
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - HISTOLOGY
    - HIST_ASSESSMENT_REVIEW
    - HISTOLOGY_RESULT
    - HISTOLOGY_RESULT_NUMERIC
    - HISTOLOGY_RESULT_UNIT
    - HIST_ICD_O_MORPH
    - HISTOLOGY_GRADE
    - MATURE_GLIAL_IMPLANTS
    - SOMATIC_MALIGNANCY_TYPE
  Immunohistochemistry_Table:
    - AGE_AT_IHC
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - IHC_TEST
    - IHC_RESULT
    - IHC_RESULT_NUMERIC
  Labs_Table:
    - AGE_AT_LAB
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - LAB_CAT
    - LAB_TEST
    - LAB_SPEC_TYPE
    - LAB_RESULT
    - LAB_RESULT_NUMERIC
    - LAB_RESULT_UNIT
    - LAB_METHOD
    - TRAUMATIC_TAP
    - THRESHOLD_HIGH
    - LAB_SEQ_METHOD
    - THRESHOLD_LOW
    - PMID_REF
    - BM_MORPHOLOGY
  Medical_History_Table:
    - MEDICAL_HISTORY
    - DYSGENETIC_GONAD
  Minimal_Residual_Disease_Table:
    - AGE_AT_MRD_ASSESSMENT
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - MRD_METHOD
    - FLOW_CYTOMETRY_TYPE
    - MRD_RESULT
    - MRD_RESULT_NUMERIC
    - MRD_RESULT_UNIT
    - MRD_SENSITIVTY
    - MRD_SAMPLE_SOURCE
    - MRD_MOLECULAR_MARKERS
  Molecular_Analysis_Table:
    - AGE_AT_MOLECULAR_ANALYSIS
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - MOLECULAR_ANALYSIS_METHOD
    - ISCN
    - INDEPEN_ABB
    - NUM_METAPHASES
    - MOLECULAR_ABNORMALITY
    - CHROMOSOME
    - GENE1
    - GENE2
    - VARIANT_TYPE
    - GENETIC_SEQ
    - AA_MUTATION
    - MOLECULAR_ABNORMALITY_RESULT
    - ALLELIC_RATIO
    - TUMOR_CLASSIFICATION
    - KARYOTYPE_STATUS
    - NUM_CHROMOSOMES
    - MOLECULAR_ANALYSIS_SAMPLE_SOURCE
    - DNA_INDEX
    - TRANSLOCATION_STATUS
  Myeloid_Sarcoma_Involvement_Table:
    - AGE_AT_DISEASE_PHASE
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - MYELOID_SARCOMA
    - MYELOID_SARCOMA_SITE
  Non_Protocol_Therapy_Table:
    - NPT_TIMING
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - NPT_TYPE
  Non_protocol_Therapy_Table_2:
    - NPT_TIMING
    - NPT_TYPE
    - Radiation_Therapy
  Off_Protocol_Therapy_Study_Table:
    - AGE_OFF
    - OFF_TYPE
    - REASON_OFF
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - Adverse_Event
    - ANOTHER_STUDY
  Patient_Reported_Outcomes_Metadata_Table:
    - STUDY_ID
    - PRO_MEASURES
  Program:
    - PROGRAM_ID
    - Cancer
    - Headquarters
    - Consortium
    - Consortium_Manager
  Radiation_Therapy_Table:
    - AGE_AT_RT_START
    - AGE_AT_RT_END
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - RT_SITE
    - RT_DOSE
    - RT_UNIT
    - TUMOR_CLASSIFICATION
    - TUMOR_TISSUE_TYPE
    - RT_LATERALITY
    - ENERGY_TYPE
    - NUM_FRACTION
    - TRANSPOSITION_ORGAN
    - BOOST
  Secondary_Malignant_Neoplasm_Table:
    - AGE_AT_SMN
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - SMN_ICD_O_MORPH
    - SMN_ICD_O_TOP
    - SMN_FIELD
  Staging_Table:
    - AGE_AT_STAGING
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - STAGE_SYSTEM
    - STAGE
  Stem_Cell_Transplant_Table:
    - AGE_AT_SCT
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - SCT_TYPE
    - SCT_SOURCE
    - SCT_DONOR_RELATIONSHIP
    - HLA_MATCH
    - NUMBER_HLA
    - NUMBER_MATCHES
    - HLA_A_RESULT
    - HLA_B_RESULT
    - HLA_C_RESULT
    - HLA_DRB1_RESULT
    - HLA_DQ_RESULT
    - SCT_CONDITIONING_TYPE
    - SCT_TBI
    - SCT_CD34_COLL
    - SCT_CD34_TRANSPLANT
    - SCT_CYCLES
  Study:
    - STUDY_ID
    - STUDY_Description
  Subject_Characteristics_Table:
    - PCDC_SUBJECT_ID
    - HONEST_BROKER_SUBJECT_ID
    - DATA_CONTRIBUTOR_ID
    - AGE_AT_ENROLLMENT
    - TREATMENT_ARM
    - ENROLLED_STATUS
    - YEAR_AT_ENROLLMENT
  Subject_Response_Table:
    - AGE_AT_RESPONSE
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - RESPONSE_CATEGORY
    - RESPONSE
    - BM_PCT_BLASTS_AT_RESPONSE
    - BM_ANALYSIS_METHOD_AT_RESPONSE
    - ANC_AT_RESPONSE
    - ANC_THRESHOLD_AT_RESPONSE
    - PLATELET_COUNT_AT_RESPONSE
    - PLATELET_THRESHOLD_AT_RESPONSE
    - RESPONSE_CRITERIA
    - RESPONSE_CRITERIA_VERSION
    - RESPONSE_METHOD
  Survival_Characteristics_Table:
    - AGE_AT_LKSS
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - LKSS
    - AGE_LOST_TO_FOLLOW_UP
    - CAUSE_OF_DEATH
    - TRM_TYPE
    - CAUSE_OF_DEATH_DETAIL
    - CAUSE_OF_DEATH_RANKING
    - LKSS_WITH_DISEASE
  Total_Dose_Table:
    - AGE_AT_TOTAL_DOSE_START
    - AGE_A_TOTAL_DOSE_END
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - ROUTE
    - ANTINEOPLASTIC_AGENT
    - NUMBER_DOSES
    - TOTAL_DOSE_ADMINISTERED
    - TOTAL_DOSE_INTENDED
    - TOTAL_DOSE_UNITS
  Transfusion_Medicine_Procedures_Table:
    - AGE_AT_TMP_START
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - TMP_TYPE
    - TMP_PRODUCT
  Tumor_Assessment_Table:
    - AGE_AT_TUMOR_ASSESSMENT
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - TUMOR_DETECTION_METHOD
    - TUMOR_CLASSIFICATION
    - TUMOR_TISSUE_TYPE
    - TUMOR_SITE
    - TUMOR_LATERALITY
    - SITE_WITHIN_BONE
    - FRACTURE
    - LONGEST_DIAM_DIM1
    - LONGEST_DIAM_DIM2
    - LONGEST_DIAM_DIM3
    - COMPUTED_VOLUME
    - ESTIMATED_VOLUME
    - TUMOR_VOLUME
    - JOINT_INVOLVEMENT
    - NODAL_INVOLVEMENT
    - SKIP_LESION
    - IPSILATERAL_NODULES
    - PLEURAL_EFFUSION
    - PLEURAL_CYTOLOGY
    - PERITONEAL_EFFUSION
    - PERITONEAL_CYTOLOGY
    - EXTENSION_SITE
    - NODAL_SITE
  Vitals_Table:
    - AGE_AT_VITALS
    - DISEASE_PHASE
    - DISEASE_PHASE_NUMBER
    - COURSE
    - COURSE_NUMBER
    - VITALS_TEST
    - VITALS_RESULT
    - VITALS_RESULT_NUMERIC
    - VITALS_RESULT_UNIT



#Relationship specifications. For example: how many studies per program; how many cases per studies.
# This also includes specifications on how these node counts should be generated.
# 1. SrcNodeCount: fixed, indicates that the "count" variable holds the counts.
# 2. SrcNodeCount: random, indicates that counts are generated from a drawing from a uniform distribution 
#    between the variable minCount and maxCount (both inclusive).
# 3. All relationships among the included nodes will automatically be created.
# 4. Do not specify relationships between nodes of the same type, e.g between two samples, two visits etc.

RelationshipSpecs:
  Program:
    Study:
      EdgeType: of_programs
      SrcNodeCount: fixed
      count: 5
      Prefix: Study
  Study:
    Subject_Characteristics_Table:
      EdgeType: of_programs
      SrcNodeCount: fixed
      count: 6
      Prefix: Subject
  Subject_Characteristics_Table:
    Transfusion_Medicine_Procedures_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: TMPT
    Subject_Response_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: SRT
    Growing_Teratoma_Syndrome_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: GTST
    Cytology_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: CT
    Secondary_Malignant_Neoplasm_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: SMNT
    Adverse_Events_Table:
      EdgeType: of_subject
      SrcNodeCount: fixed
      count: 1
      Prefix: AET
    Vitals_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: VT
    Radiation_Therapy_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: RTT
    Molecular_Analysis_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: MAT
    Stem_Cell_Transplant_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: SCTT
    Concomitant_Medications_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: CMT
    Echocardiogram_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: ET
    Demographics_Table:
      EdgeType: of_subject
      SrcNodeCount: fixed
      count: 1
      Prefix: DT
    Non_Protocol_Therapy_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: NPTT
    Tumor_Assessment_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: TAT
    Histology_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: HT
    Staging_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: ST
    Patient_Reported_Outcomes_Metadata_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: PROMT
    Survival_Characteristics_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: SCT
    Non_protocol_Therapy_Table_2:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: NPTT2
    Course_Timing_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: CTT
    Immunohistochemistry_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: IT
    Off_Protocol_Therapy_Study_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: OPTST
    Medical_History_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: MHT
    Minimal_Residual_Disease_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: MRDT
    Labs_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: LT
    Disease_Characteristics_Table:
      EdgeType: of_subject
      SrcNodeCount: fixed
      count: 1
      Prefix: DCT
    Total_Dose_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: TDT
    Biopsy_Surgical_Procedures_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: BSPT
    Cellular_Immunotherapy_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: CIT
#    File:
#      EdgeType: of_subject
#      SrcNodeCount: random
#      minCount: 2
#      maxCount: 5
#      Prefix: File
    Myeloid_Sarcoma_Involvement_Table:
      EdgeType: of_subject
      SrcNodeCount: random
      minCount: 2
      maxCount: 5
      Prefix: MSIT
    Disease_Phase_Timing_Table:
      EdgeType: of_subject
      SrcNodeCount: fixed
      count: 1
      Prefix: DPTT


